Metabolomics

Dataset Information

0

The phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 inhibitor 3PO is a modulator of neutrophil metabolism, ROS production and NET release


ABSTRACT: Neutrophils are key effector leukocytes of the innate immune system and play a pivotal role in defending the host against microbial infections. Recent studies have identified a crucial link between glycolysis and neutrophil cellular functions. We have investigated in human neutrophils, the intricate relationship between glycolysis, extracellular glucose availability, and the enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3), in the regulation of reactive oxygen species (ROS) and neutrophil extracellular trap (NET) production. We have identified that the PFKFB3 inhibitor 3PO is a key regulator of neutrophil ROS and NETs, which are both implicated in the pathogenesis of immune-mediated inflammatory diseases such as rheumatoid arthritis (RA). 3PO blocked the production of ROS and NETs in a dose-dependent manner in both RA and HC neutrophils (p<0.01), and RA neutrophils were more sensitive to lower concentrations of 3PO. Bacterial killing was only partially inhibited by 3PO, and the proportion of live neutrophils after 24h incubation was unchanged. Using NMR metabolomics, we identified that 3PO increases the concentration of lactate, phenylalanine and L-glutamine in neutrophils, as well as significantly decreasing intracellular glutathione (adj. p-value<0.05), suggesting 3PO may have molecular targets beyond PFKFB3. We also demonstrated that RA neutrophils produce ROS and NETs in culture conditions which mimic the low glucose environments encountered in the RA synovial joint. By dissecting the intricate interplay between metabolism and neutrophil effector functions, this study advances the understanding of the molecular mechanisms governing pro-inflammatory neutrophil responses and identifies 3PO as a potential therapeutic for conditions characterized by dysregulated neutrophil activation.

INSTRUMENT(S): Nuclear Magnetic Resonance (NMR) -

PROVIDER: MTBLS6215 | MetaboLights | 2025-08-14

REPOSITORIES: MetaboLights

Dataset's files

Source:
Action DRS
11.zip Other
12.zip Other
13.zip Other
14.zip Other
15.zip Other
Items per page:
1 - 5 of 26
altmetric image

Publications

The small molecule inhibitor 3PO is a modulator of neutrophil metabolism, ROS production, and NET release.

Fresneda Alarcon Michele M   Abdullah Genna Ali GA   Nolan Andy A   Linford Christina C   Meschis Maria Martina MM   Cross Andrew L AL   Sellin Andrew A   Phelan Marie M MM   Wright Helen L HL  

Clinical and experimental immunology 20250101 1


Neutrophils are key effector leukocytes of the innate immune system and play a pivotal role in defending the host against microbial infections. Recent studies have identified a crucial link between glycolysis and neutrophil cellular functions. Using human neutrophils, we have investigated the intricate relationship between glycolysis, extracellular glucose availability, and the enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3), in the regulation of reactive oxygen species (R  ...[more]

Similar Datasets

2019-02-18 | PXD011796 | Pride
2023-07-11 | MTBLS4766 | MetaboLights
2023-04-20 | GSE220693 | GEO
2024-09-12 | GSE262717 | GEO
2021-09-08 | PXD010723 | Pride
2023-03-10 | PXD036228 | Pride
2013-01-31 | E-GEOD-43890 | biostudies-arrayexpress
2013-01-31 | E-GEOD-43889 | biostudies-arrayexpress
2024-02-15 | PXD043496 | Pride
2018-12-06 | MTBLS658 | MetaboLights